US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment.
Hui HuangMei-Qing ChengDan-Ni HeMeng-Fei XianDan ZengShao-Hong WuChao-Qun LiSi-Min RuanMing-De LiMan-Xia LinMing-De LuMing KuangWei WangLi-Da ChenPublished in: European radiology (2023)
• US LI-RADS with AFP had high sensitivity and NPV in surveillance for RHCC when considering US-2/3 or AFP ≥ 20 µg/L as a criterion. • After US with AFP surveillance, patients with US-2/3 or AFP ≥ 20 µg/L should perform enhanced imaging for confirmative diagnosis. Patients with US-1 or AFP < 20 µg/L continue to repeat US with AFP surveillance. • Patients with risk factors for poor visualization scores limited the sensitivity of US surveillance in RHCC.